NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

On topic would be the question of whether NWBIO will manage to drag this out until ASCO 2021. Less on topic would be the following question posed to the many biomedical experts and just smart people that have done a lot of reading while following NWBO: What length amino-acid/protein segments does the immune system use in determining whether a given protein segment, presented on the cell surface, is a mutation? What length do they test/look-at. Not what length are the polymers, but rather, how many bases/amino acids do they look at at once?

Is it 20 amino acids long that it/they looks at? 40? 400? My guess would be 30, but I don't want to guess. There are many places where this look at the sequences occurs. Most important here would be T Cells examining strands protruding from a cell wall or presented by Dendritic cells or other strand/mutation scavengers in the lymph nodes..